Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


GlaxoSmithKline in talks for possible media review

Published on .

New York—Pharmaceutical company GlaxoSmithKline is in talks with media agencies about a possible review of its estimated $1.6 billion global media account, according to Advertising Age, a sibling publication of BtoB. The media account is now handled by multiple agencies globally. According to sources familiar with the situation, GlaxoSmithKline is conferring with agencies before opening a formal review.
Most Popular
In this article: